Q-Line Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 6 Months
About Q-Line Nutraceuticals
Q-Line Nutraceuticals Private Limited (QNPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 July 2023 (One year and six months 25 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saurabh Garg, Ajay Mahanty, and Rajalaxmi Panda serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U21009UP2023PTC185393
-
Company No.
185393
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Jul 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Q-Line Nutraceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Mahanty
|
Director | 11-Jul-2023 | Current |
|
Saurabh Garg
|
Director | 11-Jul-2023 | Current |
|
Rajalaxmi Panda
|
Director | 11-Jul-2023 | Current |
Financial Performance of Q-Line Nutraceuticals.
Enhance accessibility to Q-Line Nutraceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Q-Line Nutraceuticals?
Unlock access to Q-Line Nutraceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Syndicate Diagnostics Private LimitedSaurabh Garg is a mutual person
-
Poct Science House Private LimitedSaurabh Garg is a mutual person
-
Q-Line Biotech Private Limited
Saurabh Garg and Ajay Mahanty are mutual person
-
Heidelco Medicore Private LimitedSaurabh Garg is a mutual person
-
Sperogenx Biosciences Private LimitedSaurabh Garg is a mutual person
-
Q-Line Healthcare Private LimitedSaurabh Garg is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Q-Line Nutraceuticals?
Unlock and access historical data on people associated with Q-Line Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Q-Line Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Q-Line Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.